Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith L Knutson

Showing results (91-100 of 147) with videos related to

Pageof 15
Sort By:
Frontiers in Immunology|June 22, 2026
Identification of tumor-associated antigens with multi-cancer therapeutic potentialDaniel P Wickland, Erik Jessen, Asha Nair, et al.
Nature Nanotechnology|May 2, 2017
Multivalent bi-specific nanobioconjugate engager for targeted cancer immunotherapyHengfeng Yuan, Wen Jiang, Christina A von Roemeling, et al.
Clinical Immunology (Orlando, Fla.)|June 28, 2011
Assessing immune function by profiling cytokine release from stimulated blood leukocytes and the risk of infection in rheumatoid arthritisMegan L Krause, John M Davis, Keith L Knutson, et al.
AIDS (London, England)|March 20, 2010
Casp8p41 expression in primary T cells induces a proinflammatory responseJulie A Taylor, Nathan W Cummins, Gary D Bren, et al.
The American Journal of Pathology|May 26, 2007
Renal hemodynamic, inflammatory, and apoptotic responses to lipopolysaccharide in HO-1-/- miceMichal J Tracz, Julio P Juncos, Joseph P Grande, et al.
Clinical and Translational Gastroenterology|May 5, 2025
Higher and Sustained Cell-Mediated Immune Responses After 3 Doses of mRNA COVID-19 Vaccine in Patients With Inflammatory Bowel Disease on Anti-Tumor Necrosis Factor TherapyFreddy Caldera, Stacey Rolak, Francis A Farraye, et al.
Oncoimmunology|June 12, 2020
HLA class-I and class-II restricted neoantigen loads predict overall survival in breast cancerYingxue Ren, Yesesri Cherukuri, Daniel P Wickland, et al.
Clinical and Translational Gastroenterology|February 13, 2024
Higher and Sustained Cell-Mediated Immune Responses After 3 Doses of mRNA COVID-19 Vaccine in Patients With Inflammatory Bowel Disease on Anti-Tumor Necrosis Factor TherapyFreddy Caldera, Stacey Rolak, Francis A Farraye, et al.
Cancer Prevention Research (Philadelphia, Pa.)|November 24, 2017
Macrophagic "Crown-like Structures" Are Associated with an Increased Risk of Breast Cancer in Benign Breast DiseaseJodi M Carter, Tanya L Hoskin, M Alvaro Pena, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 27, 2011
MHC class II epitope nesting modulates dendritic cell function and improves generation of antigen-specific CD4 helper T cellsCourtney L Erskine, Christopher J Krco, Karen E Hedin, et al.
Pageof 15

Showing results (91-100 of 147) with videos related to

Sort By:
Pageof 15
Frontiers in Immunology|June 22, 2026
Identification of tumor-associated antigens with multi-cancer therapeutic potentialDaniel P Wickland, Erik Jessen, Asha Nair, et al.
Nature Nanotechnology|May 2, 2017
Multivalent bi-specific nanobioconjugate engager for targeted cancer immunotherapyHengfeng Yuan, Wen Jiang, Christina A von Roemeling, et al.
Clinical Immunology (Orlando, Fla.)|June 28, 2011
Assessing immune function by profiling cytokine release from stimulated blood leukocytes and the risk of infection in rheumatoid arthritisMegan L Krause, John M Davis, Keith L Knutson, et al.
AIDS (London, England)|March 20, 2010
Casp8p41 expression in primary T cells induces a proinflammatory responseJulie A Taylor, Nathan W Cummins, Gary D Bren, et al.
The American Journal of Pathology|May 26, 2007
Renal hemodynamic, inflammatory, and apoptotic responses to lipopolysaccharide in HO-1-/- miceMichal J Tracz, Julio P Juncos, Joseph P Grande, et al.
Clinical and Translational Gastroenterology|May 5, 2025
Higher and Sustained Cell-Mediated Immune Responses After 3 Doses of mRNA COVID-19 Vaccine in Patients With Inflammatory Bowel Disease on Anti-Tumor Necrosis Factor TherapyFreddy Caldera, Stacey Rolak, Francis A Farraye, et al.
Oncoimmunology|June 12, 2020
HLA class-I and class-II restricted neoantigen loads predict overall survival in breast cancerYingxue Ren, Yesesri Cherukuri, Daniel P Wickland, et al.
Clinical and Translational Gastroenterology|February 13, 2024
Higher and Sustained Cell-Mediated Immune Responses After 3 Doses of mRNA COVID-19 Vaccine in Patients With Inflammatory Bowel Disease on Anti-Tumor Necrosis Factor TherapyFreddy Caldera, Stacey Rolak, Francis A Farraye, et al.
Cancer Prevention Research (Philadelphia, Pa.)|November 24, 2017
Macrophagic "Crown-like Structures" Are Associated with an Increased Risk of Breast Cancer in Benign Breast DiseaseJodi M Carter, Tanya L Hoskin, M Alvaro Pena, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 27, 2011
MHC class II epitope nesting modulates dendritic cell function and improves generation of antigen-specific CD4 helper T cellsCourtney L Erskine, Christopher J Krco, Karen E Hedin, et al.
Pageof 15